Syros Pharmaceuticals, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States
Syros Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2011. It has reported private securities offerings to the US SEC, most recently $130 million sold in a notice filed in 2022.
Syros Pharmaceuticals at a glance
What does Syros Pharmaceuticals do?
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $129.8 million sold (2022).
Frequently asked questions about Syros Pharmaceuticals
Where is Syros Pharmaceuticals headquartered?
Syros Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Syros Pharmaceuticals do?
Syros Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Syros Pharmaceuticals founded?
The earliest incorporation on record for Syros Pharmaceuticals, Inc. is in 2011, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.